These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35656633)

  • 1. Home-based, tunnelled peritoneal drainage system as an alternative treatment option for patients with refractory ascites.
    Tergast TL; Griemsmann M; Stockhoff L; Heidrich B; Schirmer H; Lenzen H; Wedemeyer H; Cornberg M; Jaeckel E; Maasoumy B
    Aliment Pharmacol Ther; 2022 Aug; 56(3):529-539. PubMed ID: 35656633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites.
    Tergast TL; Griemsmann M; Stockhoff L; Port K; Heidrich B; Cornberg M; Wedemeyer H; Lenzen H; Richter N; Jaeckel E; Maasoumy B
    JAMA Netw Open; 2023 Jul; 6(7):e2322048. PubMed ID: 37410459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
    United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
    Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
    Salerno F; Cammà C; Enea M; Rössle M; Wong F
    Gastroenterology; 2007 Sep; 133(3):825-34. PubMed ID: 17678653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
    Gaba RC; Parvinian A; Casadaban LC; Couture PM; Zivin SP; Lakhoo J; Minocha J; Ray CE; Knuttinen MG; Bui JT
    Clin Radiol; 2015 May; 70(5):e51-7. PubMed ID: 25758602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis.
    Will V; Rodrigues SG; Berzigotti A
    Dig Liver Dis; 2022 Aug; 54(8):1007-1014. PubMed ID: 35016859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.
    Bai M; Qi XS; Yang ZP; Yang M; Fan DM; Han GH
    World J Gastroenterol; 2014 Mar; 20(10):2704-14. PubMed ID: 24627607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
    Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites.
    Williams DB; Waugh R; Selby W
    Aust N Z J Med; 1998 Oct; 28(5):620-6. PubMed ID: 9847951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
    Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative Transjugular Intrahepatic Portosystemic Shunt Is Associated With Decreased Postoperative Complications in Decompensated Cirrhotics Undergoing Abdominal Surgery.
    Aryan M; McPhail J; Ravi S; Harris P; Allamneni C; Shoreibah M
    Am Surg; 2022 Jul; 88(7):1613-1620. PubMed ID: 35113676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis.
    Solbach P; Höner Zu Siederdissen C; Taubert R; Ziegert S; Port K; Schneider A; Hueper K; Manns MP; Wedemeyer H; Jaeckel E
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):539-546. PubMed ID: 28350743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
    Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.